In transgenic mice, higher serum S100B levels were related to brain-region-specific and sex-dependent amyloid-β deposition, suggesting a role of S100B in the pathophysiology of Alzheimer’s disease [35,36]. Here, S100B is linked to early-onset autosomal dominant Alzheimer disease.